TCM
CRBP icon

Tang Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Tang Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-127,520
Closed -$1.61M – 105
2025
Q3 		$1.61M Hold
127,520
– – 0.06% 138
2025
Q2 		$880K Hold
127,520
– – 0.04% 162
2025
Q1 		$677K Sell
127,520
-115,133
-47% -$1.02M 0.04% 177
2024
Q4 		$2.86M Sell
242,653
-357,347
-60% -$5.99M 0.19% 93
2024
Q3 		$12.4M Buy
+600,000
New +$30.7M 0.88% 39

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Tang Capital Management's CRBP Position: Q4 2025 in Review

Tang Capital Management sold out of Corbus Pharmaceuticals (CRBP) in Q4 2025, closing a stake of 127,520 shares — an estimated $1.61M sold.

Tang Capital Management first reported a position in CRBP in Q3 2024 and held it in 5 quarters. The position peaked at $12.4M in Q3 2024. 101 funds tracked by Wall St. Rank hold CRBP as of Q4 2025.

  • Tang Capital Management reported no remaining Corbus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 127,520 Corbus Pharmaceuticals shares in Q4 2025, an estimated $1.61M.
  • Tang Capital Management first reported a position in Corbus Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Tang Capital Management's Corbus Pharmaceuticals position peaked at $12.4M in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.